Improving Clinical Decision Making with Engaging CME, Tools, & Resources
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
Katherine E. Talcott, MD
Christina Y. Weng, MD, MBA, FASRS
Roger A. Goldberg, MD, MBA
Time to Recurrence and Early Risk Indicators in BRVO-Related Macular Edema
Hidden in Plain Sight: A Modern Guide to Detecting and Managing Early Neurotrophic Keratitis
March 12, 2026
March 12, 2026 Orlando, Florida
Orlando, Florida
Real-World Switching to Faricimab from Legacy Anti-VEGFs in Wet AMD
Maria H. Berrocal, MD
Lejla Vajzovic, MD, FASRS
How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion
Ryan Quigley
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Deepak Sambhara, MD
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Eichenbaum, MD
Retinal Vein Occlusion: The Case for Prompt Treatment
Ashkan Abbey, MD
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
Diagnosis Delays in Stargardt Disease
Alexis Warren, MD
Jesse Sengillo, MD
Sruthi Arepalli, MD
Suprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
Danny Mammo, MD
Redefining The Cash-Pay Model in Modern Optometric Practice
Jason E. Compton, OD, FAAO
Elevating Clinical Efficiency
Diana Chu
Tailored Treatment in Retinal Disease: Using Biomarkers to Guide Anti-VEGF Therapy
Jennifer Caudle, DO, FACOFP
Michael Javaheri, MD, MSc, FASRS
EMPOWER - Cornea Health Diagnostic Tools
Jacob Lang, OD, FAAO
Paul Hammond, OD, FAAO
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.